MX9102173A - FNT INHIBITORS. - Google Patents

FNT INHIBITORS.

Info

Publication number
MX9102173A
MX9102173A MX9102173A MX9102173A MX9102173A MX 9102173 A MX9102173 A MX 9102173A MX 9102173 A MX9102173 A MX 9102173A MX 9102173 A MX9102173 A MX 9102173A MX 9102173 A MX9102173 A MX 9102173A
Authority
MX
Mexico
Prior art keywords
fnt
inhibitors
fnt inhibitors
Prior art date
Application number
MX9102173A
Other languages
Spanish (es)
Inventor
Klaus Max Esser
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MX9102173A publication Critical patent/MX9102173A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Agronomy & Crop Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX9102173A 1990-11-21 1991-11-21 FNT INHIBITORS. MX9102173A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61647990A 1990-11-21 1990-11-21

Publications (1)

Publication Number Publication Date
MX9102173A true MX9102173A (en) 1992-06-01

Family

ID=24469639

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102173A MX9102173A (en) 1990-11-21 1991-11-21 FNT INHIBITORS.

Country Status (14)

Country Link
EP (1) EP0558659A4 (en)
JP (1) JP3204971B2 (en)
KR (1) KR930702896A (en)
AP (1) AP259A (en)
AU (1) AU656938B2 (en)
CA (1) CA2096623A1 (en)
HU (1) HUT65838A (en)
IE (1) IE914034A1 (en)
IL (1) IL100088A (en)
MX (1) MX9102173A (en)
NZ (1) NZ240644A (en)
TW (1) TW222001B (en)
WO (1) WO1992009203A1 (en)
ZA (1) ZA919178B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014455A1 (en) * 1991-02-14 1992-09-03 The Rockefeller University METHOD FOR CONTROLLING ABNORMAL CONCENTRATION TNF α IN HUMAN TISSUES
EP0712310A1 (en) * 1993-08-04 1996-05-22 Andrulis Pharmaceuticals Corporation Use of tumor necrosis factor inhibitors together with antiviral agents and therapeutic compositions thereof against hiv infection
US5504090A (en) * 1994-03-30 1996-04-02 Trustees Of The University Of Pennsylvania Compositions and methods for the prevention and treatment of ischemia-reperfusion organ injury
US7608262B2 (en) * 1996-02-16 2009-10-27 The Kennedy Institute Of Rheumatology Methods of preventing or treating thrombosis with tumor necrosis factor antagonists
GB9703044D0 (en) 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
GB9817623D0 (en) 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
US20060079540A1 (en) * 2002-11-27 2006-04-13 Altana Pharma Ag Pde4 and pde3/4 inhibitors for use in the treatment of cachexia
DK1781657T3 (en) * 2004-02-14 2013-06-10 Glaxosmithkline Ip Dev Ltd MEDICINES WITH HM74A RECEPTOR ACTIVITY
NZ565494A (en) 2005-08-10 2011-06-30 Glaxosmithkline Llc Xanthine derivatives as selective HM74A agonists
AU2015330490B2 (en) 2014-10-09 2018-08-09 Guangdong Raynovent Biotech Co., Ltd. Hydroxyl purine compounds and applications thereof
ES2784826T3 (en) * 2015-10-29 2020-10-01 Guangdong Raynovent Biotech Co Ltd Crystalline form of a 4H-pyrazole [1,5-] benzimidazole compound, method of preparation thereof and intermediate thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US757328A (en) * 1903-02-07 1904-04-12 Boehringer & Soehne Art of preparing xanthin derivatives.
US2517410A (en) * 1947-08-15 1950-08-01 Searle & Co Hydroxy alkyl xanthines and the production thereof
US4120947A (en) * 1976-03-31 1978-10-17 Cooper Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
CH654008A5 (en) * 1979-05-22 1986-01-31 Nestle Sa PROCESS FOR THE PREPARATION OF 1,3,7-TRIALKYLXANTHINES.
DE2944568A1 (en) * 1979-11-05 1981-05-14 Institut für industrielle Pharmazie F + E GmbH, 8750 Aschaffenburg Sodium 8-chloro-theophyllinate as immunostimulant - which selectively stimulates formation of IGM antibodies
IT1200944B (en) * 1982-08-10 1989-01-27 Malesci Sas XANTHINIC DERIVATIVES, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT AND THEIR THERAPEUTIC USE
US4593095A (en) * 1983-02-18 1986-06-03 The Johns Hopkins University Xanthine derivatives
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
GB8610136D0 (en) * 1986-04-25 1986-05-29 Wellcome Found Compounds
IT1197516B (en) * 1986-12-24 1988-11-30 Abc Ist Biolog Chem Spa THEOFILLINMETYLANIC AND THEOFILLINMETYLDITIAN DERIVATIVES PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5015647A (en) * 1987-04-24 1991-05-14 Burroughs Wellcome Co. Method for treating viral infections
DE3817955A1 (en) * 1988-05-27 1989-11-30 Hoechst Ag MEDICINAL PRODUCT CONTAINING TNF INHIBITOR
FI891419A (en) * 1989-03-23 1990-09-24 Tampella Oy Ab ANORDNING I EN GAENGOEPPNINGSANORDNING FOER BORRMASKINERI.
GB8906792D0 (en) * 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds

Also Published As

Publication number Publication date
JPH06506192A (en) 1994-07-14
IE914034A1 (en) 1992-06-03
AU656938B2 (en) 1995-02-23
WO1992009203A1 (en) 1992-06-11
AP9100335A0 (en) 1992-01-31
HU9301509D0 (en) 1993-11-29
EP0558659A4 (en) 1993-10-20
JP3204971B2 (en) 2001-09-04
AU9115991A (en) 1992-06-25
KR930702896A (en) 1993-11-29
TW222001B (en) 1994-04-01
IL100088A0 (en) 1992-08-18
EP0558659A1 (en) 1993-09-08
AP259A (en) 1993-06-03
NZ240644A (en) 1994-08-26
HUT65838A (en) 1994-07-28
IL100088A (en) 1995-07-31
CA2096623A1 (en) 1992-05-22
ZA919178B (en) 1992-10-28

Similar Documents

Publication Publication Date Title
DE69112037D1 (en) WAITTRÄGER.
MX9100494A (en) FNT INHIBITORS
FI910903A0 (en) POROEST KERAMISKT KROPP.
DE69111876T2 (en) Ophthalmometer.
FI87009B (en) SKOVELHJUL FOER CENTRIFUGALPUMPAR.
MX9102173A (en) FNT INHIBITORS.
FI912962A0 (en) LJUSOEVERFOERINGSSYSTEM.
ATE124392T1 (en) 8-SULFAMYLMETHYLENE-2-AMINOTETRALINE.
DE69110793D1 (en) Time division multiplexing device.
DE59100113D1 (en) ROLLCONTAINER.
MX25113A (en) 5-LIPOXIGENASE INHIBITORS.
FI903520A (en) INDIREKT STROEMMAETNINGSKRETS.
FI904000A (en) MAGBRAEDA FOER DE ROERELSESKADADE.
MX9203345A (en) SERTINDOL PRODROGES.
FI903799A (en) DISCLOSURE FOER EN STRAOLNINGSBILD.
FI902231A (en) ANORDINATION FOR FAIRDIGAGE.
FI905618A (en) ANORDING FOR MASKINELL SKOGSROEJNING.
FI902861A0 (en) DRIVAXELSYSTEM FOR FORDON.
ES1014363Y (en) ANTILUUVIAN TENDEDERO.
ES1014476Y (en) CUBITERA.
ES1019974Y (en) BODY-CRADLE.
FI86258B (en) FILTERRULLE FOER ANDNINGSSKYDD.
ES1012467Y (en) EGG-CUP.
ES1017193Y (en) COVER-BIDET.
ES1015228Y (en) KIOSKO.